120 Participants Needed

Diagnostic Algorithm for ADHD

JN
BK
Overseen ByBeth Krone, PhD, MS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: MindTension
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method to help doctors diagnose ADHD in children and teens using the MindTension sensor, which analyzes specific responses to sound. The goal is to determine the accuracy of this method compared to traditional diagnostic tools. Participants will be divided into two groups: those with ADHD symptoms and those without any diagnosed disorders. Children aged 6 to 17 who show signs of ADHD or have no diagnosed mental health issues, and who haven't recently taken certain medications, may be suitable for this study. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance ADHD diagnosis methods.

Will I have to stop taking my current medications?

If you are currently taking stimulant medications, you will need to stop them for 3 days before testing. If you are on other psychotropic medications that can't be stopped in 3 days, you may not be eligible to participate.

What prior data suggests that the MT1 algorithm and MindTension biometric sensor device are safe for diagnosing ADHD in youth?

Research has shown that the MT1 auditory startle response patterns analysis algorithm aids doctors in diagnosing ADHD in young people by analyzing their reactions to certain sounds. It is not a treatment or medication, so it poses no risk of drug side effects.

The MindTension device, which operates with the MT1 algorithm, measures muscle responses to sounds. This non-invasive process does not involve surgery or entering the body. To date, no negative effects have been reported from using this diagnostic tool.

As this study tests a diagnostic tool rather than a new drug or treatment, the primary safety concern is the device's comfort and ease of use. Current evidence suggests that the device is well-tolerated, as it measures responses without causing harm.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a novel approach to diagnosing ADHD using the MT1 auditory startle response patterns analysis algorithm. Unlike typical diagnostic methods that rely heavily on interviews and questionnaires, this algorithm analyzes auditory startle responses, offering a potentially objective and measurable indicator of ADHD. This could lead to faster, more accurate diagnoses, reducing reliance on subjective assessments and potentially improving treatment outcomes by identifying the condition earlier.

What evidence suggests that the MT1 algorithm is effective for diagnosing ADHD?

Research shows that the MT1 algorithm, when paired with the MindTension sensor, could aid in diagnosing ADHD. This tool measures muscle reactions to sounds and uses a specialized program to analyze the results. Studies suggest that body signals like skin response, heart rate changes, and skin temperature can help identify ADHD. The MT1 algorithm uses this information to support accurate diagnoses. Early findings indicate it can effectively assist healthcare providers in diagnosing ADHD in young people. Participants in this trial will undergo evaluation with the MT1 algorithm to assess its effectiveness in diagnosing ADHD compared to established clinical methods.12345

Who Is on the Research Team?

JN

Jeffrey Newcorn, MD Professor

Principal Investigator

Director, Division of ADHD and Learning Disorders Icahn School of Medicine at Mount Sinai

Are You a Good Fit for This Trial?

This trial is for children aged 6 to 17 who may have ADHD. They must be willing to follow the study rules and can't have taken stimulants recently, or they must stop them for three days before testing. Kids with ADHD symptoms confirmed by specific assessments are included, while those without any diagnosable disorder on these tests are excluded.

Inclusion Criteria

1. Parent provision of signed and dated informed consent form
2. Child stated willingness to comply with all study procedures and availability for the duration of the study
3. Any gender, aged 6 to 17 years
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Clinical Assessment

Participants undergo clinical assessment using the MT1 algorithm and standard diagnostic interviews

1-2 days
1 visit (in-person)

Follow-up

Participants are monitored for agreement between MT1 output and specialist clinician diagnosis

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • MT1 Auditory startle response patterns analysis algorithm
Trial Overview The study is testing a new tool called the MT1 algorithm with a device named MindTension that measures how kids react to sounds. It's being compared to an established test (T.O.V.A.) to see if it helps doctors diagnose ADHD more accurately in young people.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Non-ADHD groupExperimental Treatment2 Interventions
Group II: ADHD groupExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

MindTension

Lead Sponsor

Trials
2
Recruited
160+

Published Research Related to This Trial

The study highlights the potential of artificial intelligence (AI) to enhance the early diagnosis of ADHD by reviewing various diagnostic tools, including brain MRI, physiological signals, and performance tests, which could lead to improved treatment outcomes.
It identifies significant research gaps, such as the lack of publicly available datasets for ADHD assessment beyond MRI and the underutilization of data from wearable devices, suggesting that future work should focus on these areas to develop a comprehensive AI-supported diagnostic framework.
Automated detection of ADHD: Current trends and future perspective.Loh, HW., Ooi, CP., Barua, PD., et al.[2022]
The study analyzed resting-state EEG signals from 61 children with ADHD and 60 healthy children, revealing distinct EEG patterns that could aid in diagnosing ADHD.
Using advanced classification algorithms, particularly the Bernoulli Naive Bayes classifier, the research achieved a high accuracy of 96%, suggesting that EEG analysis could be a reliable supplementary tool for ADHD diagnosis.
Electroencephalogram (EEG) based prediction of attention deficit hyperactivity disorder (ADHD) using machine learning.Ahire, N., Awale, RN., Wagh, A.[2023]
The integrated device, combining EEG and CCD motion sensors, provides an objective measurement of ADHD by analyzing attention and movement patterns in preschoolers aged 3-5 years during structured tasks.
Statistical analysis showed a significant correlation between the device's objective assessment of ADHD and traditional clinical evaluations, suggesting it could enhance diagnostic accuracy for ADHD.
Integration of electroencephalogram (EEG) and motion tracking sensors for objective measure of attention-deficit hyperactivity disorder (MAHD) in pre-schoolers.Bhattacharyya, N., Singh, S., Banerjee, A., et al.[2022]

Citations

Diagnostic Algorithm for ADHDThis study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers in ...
A Comparative Study to Evaluate a Novel Algorithm As ...This study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers.
A Comparative Study to Evaluate a Novel Algorithm As ...This study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers in ...
Study Details | NCT05753969 | The Efficacy of "Mindtesion" ...Mindtension device measures the orbicularis muscle response to auditory stimuli, the device is backed up by an algorithm that calculate the several ...
Machine learning-enabled detection of attention-deficit ...The main aim of this study was to investigate whether physiological data (ie, Electrodermal Activity, Heart Rate Variability, and Skin Temperature) can serve ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security